Forma farmacéutica sólida oral ideal para poblaciones pediátricas y geriátricas, así como para pacientes con dificultades de deglución.
Parvulet is an oral solid dosage form that, with the application of water, achieves a texture similar to applesauce
- Se administra fácilmente en 30 segundos
- Ayuda a la deglución integrada en la fórmula
- Imita el mecanismo natural de deglución sin riesgo de asfixia
- Disponible en gránulos dispersables y comprimidos
Parvulet aborda múltiples retos
- Ideal para pacientes con dificultades para tragar
- Pacientes disfágicos
- Pacientes con mucositis
- Población pediátrica y geriátrica
- Permite una alta carga de fármaco
- Dosificación precisa en cada tratamiento
- Mejora la adherencia del paciente
- Textura fácil de tragar
- Enmascarado para el gusto y el olfato
Parvulet es un formato fácil de usar para el paciente
Los estudios demuestran que el 60-79% de la población geriátrica y el 25-45% de la pediátrica experimentarán dificultades para tragar.
Forma farmacéutica sólida oral con textura final similar a la de la compota de manzana:
- Se administra fácilmente en 30 segundos
- Ayuda a la deglución integrada en la fórmula
- Imita el mecanismo natural de deglución sin riesgo de asfixia
- Disponible en gránulos dispersables y comprimidos
Hable con un experto
Dr. Srinivasan Shanmugam
Executive Director, Pharmaceutical Sciences, Business Support, and New Technologies
Dr. Srinivasan Shanmugam is involved in the development and expansion of Adare’s pharmaceutical technology portfolio and supports product development, co-development, and tech transfer opportunities. Dr. Shanmugam has a Ph.D. M.S., and a B.S. in Pharmacy. Dr. Shanmugam has more than 20 years of experience in designing and development of conventional, NDDS/alternate, advanced/modified drug delivery systems, and pharmaceutical platform technologies for oral and other routes of administration. His expertise includes enabling technologies for challenging drugs and developing platform technologies. Additionally, his expertise includes patient-centric solutions focusing on pediatric and geriatric populations to achieve dose convenience, flexibility, and precision. Dr. Shanmugam has published numerous research articles, holds multiple patents, and is a reviewer/editorial member of various prestigious journals. Shanmugam’s recent work focuses on product development solutions for special patient populations like pediatric and geriatric populations.
